Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 254 articles:
HTML format
Text format



Single Articles


    June 2018
  1. MAC AOGAIN M, Chandrasekaran R, Lim Yick Hou A, Teck Boon L, et al
    IMMUNOLOGICAL COROLLARY OF THE PULMONARY MYCOBIOME IN BRONCHIECTASIS: THE CAMEB STUDY.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00766-2018.
    PubMed     Text format     Abstract available


  2. RONIT A, Kristensen T, Hoseth VS, Abou-Kassem D, et al
    Computed tomography quantification of emphysema in people living with HIV and uninfected controls.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00296-2018.
    PubMed     Text format     Abstract available


  3. GOMEZ REAL F, Burgess JA, Villani S, Dratva J, et al
    Maternal age at delivery, lung function and asthma in offspring: a population-based survey.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    May 2018
  4. DUFETELLE E, Bokov P, Delclaux C, Beydon N, et al
    Should reversibility be assessed in all asthmatic children with normal spirometry?
    Eur Respir J. 2018 May 31. pii: 13993003.00373-2018.
    PubMed     Text format    


  5. HYLAND ME, Jones RC, Lanario JW, Masoli M, et al
    The construction and validation of the Severe Asthma Questionnaire (SAQ).
    Eur Respir J. 2018 May 24. pii: 13993003.00618-2018.
    PubMed     Text format     Abstract available


  6. BIDAD N, Barnes N, Griffiths C, Horne R, et al
    UNDERSTANDING PATIENTS' PERCEPTIONS OF ASTHMA CONTROL: A QUALITATIVE STUDY.
    Eur Respir J. 2018 May 17. pii: 13993003.01346-2017.
    PubMed     Text format     Abstract available


  7. BURGE PS, Moore VC, Robertson AS, Walters GI, et al
    Do laboratory challenge tests for occupational asthma represent what happens in the workplace?
    Eur Respir J. 2018 May 10. pii: 13993003.00059-2018.
    PubMed     Text format     Abstract available


    April 2018
  8. LOEWEN K, Monchka B, Mahmud SM, Jong G', et al
    Prenatal antibiotic exposure and childhood asthma: a population-based study.
    Eur Respir J. 2018 Apr 20. pii: 13993003.02070-2017.
    PubMed     Text format     Abstract available


  9. TSAI YH, Parker JS, Yang IV, Kelada SNP, et al
    Meta-Analysis of Airway Epithelia Gene Expression in Asthma.
    Eur Respir J. 2018 Apr 12. pii: 13993003.01962-2017.
    PubMed     Text format     Abstract available


  10. TAKAHASHI K, Pavlidis S, Ng Kee Kwong F, Hoda U, et al
    Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis.
    Eur Respir J. 2018 Apr 12. pii: 13993003.02173-2017.
    PubMed     Text format     Abstract available


  11. HAVET A, Zerimech F, Sanchez M, Siroux V, et al
    Outdoor air pollution, exhaled 8-isoprostane and current asthma in adults: the EGEA study.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    March 2018
  12. HANCOX RJ, Pavord ID, Sears MR
    Associations between blood eosinophils and decline in lung function among adults with and without asthma.
    Eur Respir J. 2018 Mar 21. pii: 13993003.02536-2017.
    PubMed     Text format     Abstract available


  13. HUMBERT M, Taille C, Mala L, Le Gros V, et al
    Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02523-2017.
    PubMed     Text format     Abstract available


  14. SHTEINBERG M, Stein N, Adir Y, Ken-Dror S, et al
    Prevalence, risk factors and prognosis of Non tuberculous mycobacteria infection among people with bronchiectasis: a population survey.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02469-2017.
    PubMed     Text format    


  15. CHANOINE S, Sanchez M, Pin I, Temam S, et al
    Multimorbidity-medications and poor asthma prognosis.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02114-2017.
    PubMed     Text format     Abstract available


  16. TO T, Feldman LY, Zhu J, Gershon AS, et al
    Asthma Health Services Utilization Before, During, and After Pregnancy: A Population-Based Cohort Study.
    Eur Respir J. 2018 Mar 8. pii: 13993003.00209-2018.
    PubMed     Text format     Abstract available


  17. LEE J, Ren Tay T, Radhakrishna N, Hore-Lacy F, et al
    Non-adherence in the era of severe asthma biologics and thermoplasty.
    Eur Respir J. 2018 Mar 8. pii: 13993003.01836-2017.
    PubMed     Text format     Abstract available


  18. DIJK FN, Xu C, Melen E, Carsin AE, et al
    Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  19. HESTER KLM, Newton J, Rapley T, Ryan V, et al
    Information and education provision in bronchiectasis: co-development and evaluation of a novel patient-driven resource in a digital era.
    Eur Respir J. 2018 Mar 1. pii: 13993003.02402-2017.
    PubMed     Text format    


    February 2018
  20. PERRY MM, Lavender P, Scott Kuo CH, Galea F, et al
    DNA methylation modules in airway smooth muscle are associated with asthma severity.
    Eur Respir J. 2018 Feb 15. pii: 13993003.01068-2017.
    PubMed     Text format    


  21. TURNER S, Fielding S, Devereux G
    First trimester fetal size and prescribed asthma medication at 15 years of age.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  22. NAGAKUMAR P, Gambir N, Sanghani N, Hall P, et al
    Role of a prolonged inpatient admission when evaluating children with problematic severe asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format    



  23. "Global strategy for asthma management and prevention: GINA executive summary." E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel a
    Eur Respir J. 2018;51.
    PubMed     Text format    


  24. MARTINEZ-GARCIA MA
    Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  25. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  26. LAVIGNE E, Belair MA, Rodriguez Duque D, Do MT, et al
    Effect modification of perinatal exposure to air pollution and childhood asthma incidence.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01884-2017.
    PubMed     Text format     Abstract available


  27. SHAW D
    Putting the brake on accelerated lung function decline in asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  28. GRZESKOWIAK LE, Smithers LG, Grieger JA, Bianco-Miotto T, et al
    Asthma treatment impacts time to pregnancy: evidence from the international SCOPE study.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  29. COUMOU H, Westerhof GA, de Nijs SB, Zwinderman AH, et al
    Predictors of accelerated decline in lung function in adult-onset asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  30. CELLI BR, Locantore N, Tal-Singer R, Riley J, et al
    Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  31. PEKKANEN J, Valkonen M, Taubel M, Tischer C, et al
    Indoor bacteria and asthma in adults: a multicentre case-control study within ECRHS II.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  32. HACCURIA A, Van Muylem A, Malinovschi A, Doan V, et al
    Small airways dysfunction: the link between allergic rhinitis and allergic asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    January 2018
  33. MANISCALCO M, Paris D, Melck DJ, Molino A, et al
    Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study.
    Eur Respir J. 2018 Jan 18. pii: 13993003.01825-2017.
    PubMed     Text format    


  34. CHALMERS JD, Polverino E
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  35. GUAN WJ, Huang Y, Chen CL, Chen RC, et al
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  36. JORUP C, Lythgoe D, Bisgaard H
    Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  37. SULAIMAN I, Greene G, MacHale E, Seheult J, et al
    A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  38. GAGA M, Samitas K, Zervas E
    Inhaler adherence in severe asthma: is there an electronic solution?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  39. TONG X, Wang D, Liu S, Ma Y, et al
    Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  40. WONG C, Sullivan C, Jayaram L
    ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  41. CHALMERS JD, Ringshausen FC, Harris B, Elborn JS, et al
    Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  42. MUNOZ G, de Gracia J, Buxo M, Alvarez A, et al
    Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  43. CHOTIRMALL SH, Chalmers JD
    RESPIRE: breathing new life into bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  44. AKSAMIT T, De Soyza A, Bandel TJ, Criollo M, et al
    RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  45. DE SOYZA A, Aksamit T, Bandel TJ, Criollo M, et al
    RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    December 2017
  46. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  47. BOUSQUET J, Brusselle G, Buhl R, Busse WW, et al
    Care pathways for the selection of a biologic in severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  48. AMIRAV I, Newhouse MT
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  49. MORJARIA JB, Rigby AS, Morice AH
    Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  50. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    Standardised classification of the aetiology of bronchiectasis using an objective algorithm.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  51. SONG Y, Khoo SK, Lee KH, Makela M, et al
    Dual responses of CD14 methylation to distinct environments: a role in asthma and allergy.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  52. ANDRIANJAFIMASY M, Zerimech F, Akiki Z, Huyvaert H, et al
    Oxidative stress biomarkers and asthma characteristics in adults of the EGEA study.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  53. MCDONALD VM, Yorke J
    Adherence in severe asthma: time to get it right.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  54. DESLEE G, Leroy S, Perotin JM, Mal H, et al
    Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  55. JOCHMANN A, Artusio L, Jamalzadeh A, Nagakumar P, et al
    Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    November 2017
  56. LIPWORTH BJ, Jabbal S
    Un-diagnosing persistent adult asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  57. SALEH AD, Kwok B, Brown JS, Hurst JR, et al
    Correlates and assessment of excess cardiovascular risk in bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  58. KOLEVA PT, Tun HM, Konya T, Guttman DS, et al
    Sex-specific impact of asthma during pregnancy on infant gut microbiota.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  59. BOURDIN A, Molinari N, Vachier I, Pahus L, et al
    Mortality: a neglected outcome in OCS-treated severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    October 2017
  60. VAN DEN WIJNGAART LS, Roukema J, Boehmer ALM, Brouwer ML, et al
    A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  61. DUMAS O, Wiley AS, Quinot C, Varraso R, et al
    Occupational exposure to disinfectants and asthma control in US nurses.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  62. VAN DEN WIJNGAART LS, Kievit W, Roukema J, Boehmer ALM, et al
    Online asthma management for children is cost-effective.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  63. GOMEZ JL, Yan X, Holm CT, Grant N, et al
    Characterisation of asthma subgroups associated with circulating YKL-40 levels.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  64. "Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies." Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian S
    Eur Respir J. 2017;50.
    PubMed     Text format    


  65. HEEDERIK D
    Occupational exposure and asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  66. BOWATTE G, Erbas B, Lodge CJ, Knibbs LD, et al
    Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  67. BUSH A, Pavord ID
    After the asthmas: Star Wars and Star Trek.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  68. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  69. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  70. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  71. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  72. POLVERINO E, Goeminne PC, McDonnell MJ, Aliberti S, et al
    European Respiratory Society guidelines for the management of adult bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  73. WENZEL SE, Brillhart S, Nowack K
    An invisible disease: severe asthma is more than just "bad asthma".
    Eur Respir J. 2017;50.
    PubMed     Text format    


  74. FOSTER JM, McDonald VM, Guo M, Reddel HK, et al
    "I have lost in every facet of my life": the hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  75. ERJ September Podcast: The hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  76. HEKKING PP, Loza MJ, Pavlidis S, De Meulder B, et al
    Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    August 2017
  77. SIN DD, Leung JM, Wechsler ME
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  78. TOMMOLA M, Ilmarinen P, Tuomisto LE, Kankaanranta H, et al
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  79. BATEMAN ED, Guerreros AG, Brockhaus F, Holzhauer B, et al
    Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  80. PRETOLANI M, Soussan D, Poirier I, Thabut G, et al
    Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  81. ERJ August Podcast: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  82. MICHILS A, Haccuria A, Michiels S, Van Muylem A, et al
    Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  83. THOMSON NC, Chanez P
    How effective is bronchial thermoplasty for severe asthma in clinical practice?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  84. CHUPP G, Laviolette M, Cohn L, McEvoy C, et al
    Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    July 2017
  85. COTTIN V
    Combined pulmonary fibrosis and emphysema: bad and ugly all the same?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  86. JACOB J, Bartholmai BJ, Rajagopalan S, Kokosi M, et al
    Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    June 2017
  87. CARPAIJ OA, Nieuwenhuis MAE, Koppelman GH, van den Berge M, et al
    Childhood factors associated with complete and clinical asthma remission at 25 and 49 years.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  88. MARTINEZ-GARCIA MA, Maiz-Carro L
    The challenge of defining exacerbation in bronchiectasis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  89. HILL AT, Haworth CS, Aliberti S, Barker A, et al
    Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available



  90. "The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts." Louise Fleming, Clare Murray, Aruna T. Bansal, Simone Hashimoto, Hans Bisgaard, Andrew Bush, Urs Frey, Gunilla Hedlin, Florian Singer, Wim M. va
    Eur Respir J. 2017;49.
    PubMed     Text format    



  91. "Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort." Dominick E. Shaw, Ana R. Sousa, Stephen J. Fowler, Louise J. Fleming, Graham Roberts, Julie Corfield, Ioannis Pandis, Aruna T. Bansal, Elisabeth H. Bel,
    Eur Respir J. 2017;49.
    PubMed     Text format    


  92. AL SALLAKH MA, Vasileiou E, Rodgers SE, Lyons RA, et al
    Defining asthma and assessing asthma outcomes using electronic health record data: a systematic scoping review.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  93. DUNICAN EM, Fahy JV
    Asthma and corticosteroids: time for a more precise approach to treatment.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  94. BERTHON BS, Gibson PG, Wood LG, MacDonald-Wicks LK, et al
    A sputum gene expression signature predicts oral corticosteroid response in asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  95. SCHLAPBACH LJ, Straney L, Gelbart B, Alexander J, et al
    Burden of disease and change in practice in critically ill infants with bronchiolitis.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  96. BUHL R, Humbert M, Bjermer L, Chanez P, et al
    Severe eosinophilic asthma: a roadmap to consensus.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  97. MIRAVITLLES M
    Diagnosis of asthma-COPD overlap: the five commandments.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  98. BOUSQUET J, Chavannes NH, Guldemond N, Haahtela T, et al
    Realising the potential of mHealth to improve asthma and allergy care: how to shape the future.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  99. MCDONALD VM, Gibson PG
    "To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  100. HIMES BE, Ortega VE
    Making progress toward understanding the genetic architecture of asthma in the most affected US ethnic group.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  101. HERBERT C, Kumar RK
    Ambient air pollution and asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  102. MIRAVITLLES M, Alvarez-Gutierrez FJ, Calle M, Casanova C, et al
    Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  103. EDWARDS MR, Saglani S, Schwarze J, Skevaki C, et al
    Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  104. COSIO BG, Perez de Llano L, Lopez Vina A, Torrego A, et al
    Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  105. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Differences between asthma-COPD overlap syndrome and adult-onset asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  106. MASEFIELD S, Edwards J, Hansen K, Hamerlijnck D, et al
    The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP).
    Eur Respir J. 2017;49.
    PubMed     Text format    


  107. PAPADOPOULOS NG, Androutsopoulou A, Akdis C, Dahlen SE, et al
    Asthma research in Europe: a transformative agenda for innovation and competitiveness.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  108. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    An evidence-based, point-of-care tool to guide completion of asthma action plans in practice.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  109. THOMSON NC
    Asthma and smoking-induced airway disease without spirometric COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  110. AZAD MB, Vehling L, Lu Z, Dai D, et al
    Breastfeeding, maternal asthma and wheezing in the first year of life: a longitudinal birth cohort study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  111. BONTEN TN, Kasteleyn MJ, de Mutsert R, Hiemstra PS, et al
    Defining asthma-COPD overlap syndrome: a population-based study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  112. SIMPSON AJ, Honkoop PJ, Kennington E, Snoeck-Stroband JB, et al
    Perspectives of patients and healthcare professionals on mHealth for asthma self-management.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  113. BERAIR R, Hartley R, Mistry V, Sheshadri A, et al
    Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  114. YAN Q, Brehm J, Pino-Yanes M, Forno E, et al
    A meta-analysis of genome-wide association studies of asthma in Puerto Ricans.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  115. HTET TD, Teede HJ, de Courten B, Loxton D, et al
    Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  116. OLVEIRA C, Martinez-Garcia MA
    Health-related quality of life questionnaires in bronchiectasis: the simplest way to quantify complexity.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  117. SPINOU A, Siegert RJ, Guan WJ, Patel AS, et al
    The development and validation of the Bronchiectasis Health Questionnaire.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  118. AAMLI GAGNAT A, Gjerdevik M, Gallefoss F, Coxson HO, et al
    Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  119. COATES AL, Wanger J, Cockcroft DW, Culver BH, et al
    ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    April 2017
  120. VALLIERES E, Tumelty K, Tunney MM, Hannah R, et al
    Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  121. HILLIAM Y, Moore MP, Lamont IL, Bilton D, et al
    Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  122. FRIJA-MASSON J, Martin C, Regard L, Lothe MN, et al
    Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  123. O'DONNELL DE, Casaburi R, Frith P, Kirsten A, et al
    Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  124. FANER R, Sibila O, Agusti A, Bernasconi E, et al
    The microbiome in respiratory medicine: current challenges and future perspectives.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  125. KNEIDINGER N, Milger K, Janitza S, Ceelen F, et al
    Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    March 2017
  126. GRAS D, Martinez-Anton A, Bourdin A, Garulli C, et al
    Human bronchial epithelium orchestrates dendritic cell activation in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  127. MUNOZ-CANO R, Torrego A, Bartra J, Sanchez-Lopez J, et al
    Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study).
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  128. DEBRAY MP, Dombret MC, Pretolani M, Thabut G, et al
    Early computed tomography modifications following bronchial thermoplasty in patients with severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  129. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  130. SCAGNOLARI C, Midulla F, Nenna R, Papoff P, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  131. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  132. STERK PJ
    A good asthma catch by professional fishing.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  133. BARALDO S, Papi A, Saetta M, Contoli M, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  134. REINKE SN, Gallart-Ayala H, Gomez C, Checa A, et al
    Metabolomics analysis identifies different metabotypes of asthma severity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  135. STOCKLEY JA, Ismail AM, Hughes SM, Edgar R, et al
    Maximal mid-expiratory flow detects early lung disease in alpha1-antitrypsin deficiency.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  136. LEDUC C, Antoni D, Charloux A, Falcoz PE, et al
    Comorbidities in the management of patients with lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  137. PERSSON LJ, Aanerud M, Hardie JA, Miodini Nilsen R, et al
    Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  138. HUSEBO GR, Gronseth R, Lerner L, Gyuris J, et al
    Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  139. WEDZICHA JA ERS CO-CHAIR, Miravitlles M, Hurst JR, Calverley PM, et al
    Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  140. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  141. CROOK S, Busching G, Schultz K, Lehbert N, et al
    A multicentre validation of the 1-min sit-to-stand test in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  142. WILLIAMS MT, John D, Frith P
    Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  143. VOGELMEIER CF, Criner GJ, Martinez FJ, Anzueto A, et al
    Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  144. PAPI A, Saetta M, Fabbri L
    Severe asthma: phenotyping to endotyping or vice versa?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  145. KUO CS, Pavlidis S, Loza M, Baribaud F, et al
    T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  146. BRUMPTON B, Mai XM, Langhammer A, Laugsand LE, et al
    Prospective study of insomnia and incident asthma in adults: the HUNT study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  147. ZOLLER B, Pirouzifard M, Memon AA, Sundquist J, et al
    Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case-control study from Sweden.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  148. LORX A, Czovek D, Gingl Z, Makan G, et al
    Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  149. MOLIMARD M, Raherison C, Lignot S, Balestra A, et al
    Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  150. LOWES D, Al-Shair K, Newton PJ, Morris J, et al
    Predictors of mortality in chronic pulmonary aspergillosis.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    January 2017
  151. BAHMER T, Waschki B, Schatz F, Herzmann C, et al
    Physical activity, airway resistance and small airway dysfunction in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  152. DE-TORRES JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, et al
    Telomere length, COPD and emphysema as risk factors for lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  153. GRIGG J
    Tiotropium in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  154. ELLWOOD P, Asher MI, Billo NE, Bissell K, et al
    The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available



  155. ERJ January Podcast: the BioSHaRE approach to understanding of the effects of air pollution on asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  156. ALIBERTI S, Dhar R, Aksamit TR, Morgan L, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  157. GUAN WJ, Gao YH, Yuan JJ, Chen RC, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  158. KARIMI R, Tornling G, Forsslund H, Mikko M, et al
    Differences in regional air trapping in current smokers with normal spirometry.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  159. BENMERAD M, Slama R, Botturi K, Claustre J, et al
    Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  160. KUNZ LI, Ten Hacken NH, Lapperre TS, Timens W, et al
    Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  161. GREULICH T, Nell C, Hohmann D, Grebe M, et al
    The prevalence of diagnosed alpha1-antitrypsin deficiency and its comorbidities: results from a large population-based database.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    December 2016
  162. GAGA M, Zervas E, Humbert M
    Targeting immunoglobulin E in non-atopic asthma: crossing the red line?
    Eur Respir J. 2016;48:1538-1540.
    PubMed     Text format    


    November 2016
  163. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2016 Nov 11. pii: ERJ-00969-2016. doi: 10.1183/13993003.00969-2016
    PubMed     Text format     Abstract available


  164. SHIN S, Park HY, Kim H, Kim HK, et al
    Joint effect of airflow limitation and emphysema on postoperative outcomes in early-stage nonsmall cell lung cancer.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01148-2016. doi: 10.1183/13993003.01148-2016.
    PubMed     Text format     Abstract available


  165. HAMELMANN E, Bernstein JA, Vandewalker M, Moroni-Zentgraf P, et al
    A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01100-2016. doi: 10.1183/13993003.01100-2016.
    PubMed     Text format     Abstract available


  166. LEZMI G, Galmiche-Rolland L, Rioux S, Jaubert F, et al
    Mast cells are associated with exacerbations and eosinophilia in children with severe asthma.
    Eur Respir J. 2016;48:1320-1328.
    PubMed     Text format     Abstract available


  167. WILSON SJ, Ward JA, Sousa AR, Corfield J, et al
    Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.
    Eur Respir J. 2016;48:1307-1319.
    PubMed     Text format     Abstract available


  168. FLEMING L, Saglani S, Bush A
    Asthma attacks: should we nail our colours to the mast (cell)?
    Eur Respir J. 2016;48:1261-1264.
    PubMed     Text format    


  169. HASEGAWA K, Mansbach JM, Ajami NJ, Espinola JA, et al
    Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.
    Eur Respir J. 2016;48:1329-1339.
    PubMed     Text format     Abstract available


    October 2016
  170. CAI Y, Zijlema WL, Doiron D, Blangiardo M, et al
    Ambient air pollution, traffic noise and adult asthma prevalence: a BioSHaRE approach.
    Eur Respir J. 2016 Oct 20. pii: ERJ-02127-2015. doi: 10.1183/13993003.02127-2015
    PubMed     Text format     Abstract available


  171. PILLAI P, Chan YC, Wu SY, Ohm-Laursen L, et al
    Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma.
    Eur Respir J. 2016 Oct 20. pii: ERJ-01501-2015. doi: 10.1183/13993003.01501-2015
    PubMed     Text format     Abstract available


  172. CHEN YC, Liou TH, Chen PC, Chiang BL, et al
    Growth trajectories and asthma/rhinitis in children: a longitudinal study in Taiwan.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00741-2016. doi: 10.1183/13993003.00741-2016
    PubMed     Text format     Abstract available


  173. CHEN W, Lynd LD, FitzGerald JM, Marra CA, et al
    Excess medical costs in patients with asthma and the role of comorbidity.
    Eur Respir J. 2016 Oct 6. pii: ERJ-01141-2016. doi: 10.1183/13993003.01141-2016.
    PubMed     Text format     Abstract available


  174. SCHWARZE J, Fitch PM, Heimweg J, Errington C, et al
    Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00841-2016. doi: 10.1183/13993003.00841-2016.
    PubMed     Text format    


  175. MAGNUS MC, Haberg SE, Magnus P, Engeland A, et al
    Pre-eclampsia and childhood asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00673-2016. doi: 10.1183/13993003.00673-2016.
    PubMed     Text format     Abstract available


  176. MAO B, Yang JW, Lu HW, Xu JF, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1247-1248.
    PubMed     Text format    


  177. GAO YH, Guan WJ, Chen RC, Zhang GJ, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1246-1247.
    PubMed     Text format    


  178. POYNTER ME, Irvin CG
    Interleukin-6 as a biomarker for asthma: hype or is there something else?
    Eur Respir J. 2016;48:979-981.
    PubMed     Text format    


  179. HAMBLETON K, Pavord ID
    What can we learn from blood granulocyte patterns in patients with asthma?
    Eur Respir J. 2016;48:976-978.
    PubMed     Text format    


    September 2016
  180. TOMMOLA M, Ilmarinen P, Tuomisto LE, Haanpaa J, et al
    The effect of smoking on lung function: a clinical study of adult-onset asthma.
    Eur Respir J. 2016 Sep 22. pii: ERJ-00850-2016. doi: 10.1183/13993003.00850-2016
    PubMed     Text format     Abstract available



  181. ERJ September Podcast: research priorities in bronchiectasis.
    Eur Respir J. 2016;48:E69.
    PubMed     Text format    


  182. VAN DEN WIJNGAART LS, Roukema J, Merkus PJ
    Monitoring asthma: no matter how?
    Eur Respir J. 2016;48:614-6.
    PubMed     Text format    


  183. ROBINSON DS
    Assessing severe asthma.
    Eur Respir J. 2016;48:611-3.
    PubMed     Text format    


  184. GRAS D, Chanez P
    New sociology for better understanding severe eosinophilic asthma: introducing the SOCS family.
    Eur Respir J. 2016;48:608-10.
    PubMed     Text format    


  185. AHMADIZAR F, Vijverberg SJ, Arets HG, de Boer A, et al
    Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00766-2016. doi: 10.1183/13993003.00766-2016.
    PubMed     Text format     Abstract available


    August 2016
  186. ILMARINEN P, Tuomisto LE, Niemela O, Danielsson J, et al
    Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma.
    Eur Respir J. 2016 Aug 18. pii: ERJ-02198-2015. doi: 10.1183/13993003.02198-2015
    PubMed     Text format     Abstract available


  187. NADIF R, Siroux V, Boudier A, le Moual N, et al
    Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00336-2016. doi: 10.1183/13993003.00336-2016.
    PubMed     Text format     Abstract available


  188. LEHTIMAKI L, Csonka P, Makinen E, Isojarvi J, et al
    Predictive value of exhaled nitric oxide in the management of asthma: a systematic review.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00699-2016. doi: 10.1183/13993003.00699-2016.
    PubMed     Text format     Abstract available


  189. KING GG, Thamrin C
    Complex lung function in severe asthma: seeing is believing.
    Eur Respir J. 2016;48:294-6.
    PubMed     Text format    


  190. PETERS MC, Fahy JV
    Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma.
    Eur Respir J. 2016;48:291-3.
    PubMed     Text format    


  191. BARALDO S, Turato G, Cosio MG, Saetta M, et al
    Which CD8+ T-cells in asthma? Attacking or defending?
    Eur Respir J. 2016;48:287-90.
    PubMed     Text format    


    July 2016
  192. USEMANN J, Fuchs O, Anagnostopoulou P, Korten I, et al
    Predictive value of exhaled nitric oxide in healthy infants for asthma at school age.
    Eur Respir J. 2016 Jul 7. pii: ERJ-00439-2016. doi: 10.1183/13993003.00439-2016.
    PubMed     Text format    



  193. "Tidal flow variability measured by impedance pneumography relates to childhood asthma risk." Ville-Pekka Seppa, Anna S. Pelkonen, Anne Kotaniemi-Syrjanen, Jari Viik, Mika J. Makela and L. Pekka Malmberg. Eur Respir J 2016; 47: 1687-1696.
    Eur Respir J. 2016;48:285.
    PubMed     Text format    


    June 2016
  194. VAN DER MEER AN, Pasma H, Kempenaar-Okkema W, Pelinck JA, et al
    A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00220-2016. doi: 10.1183/13993003.00220-2016
    PubMed     Text format     Abstract available


  195. SIN DD, Miravitlles M, Mannino DM, Soriano JB, et al
    What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00436-2016. doi: 10.1183/13993003.00436-2016
    PubMed     Text format     Abstract available


  196. DORAN E, Choy DF, Shikotra A, Butler CA, et al
    Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00400-2015. doi: 10.1183/13993003.00400-2015
    PubMed     Text format     Abstract available


  197. FISHER JA, Puett RC, Hart JE, Camargo CA Jr, et al
    Particulate matter exposures and adult-onset asthma and COPD in the Nurses' Health Study.
    Eur Respir J. 2016 Jun 10. pii: ERJ-00845-2015. doi: 10.1183/13993003.00845-2015
    PubMed     Text format    


  198. ALIBERTI S, Masefield S, Polverino E, De Soyza A, et al
    Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration.
    Eur Respir J. 2016 Jun 10. pii: ERJ-01888-2015. doi: 10.1183/13993003.01888-2015
    PubMed     Text format     Abstract available



  199. "Asthma inhaler adherence determinants in adults: systematic review of observational data." Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994-1018.
    Eur Respir J. 2016;47:1892.
    PubMed     Text format    


  200. SORIANO JB, Serrano J
    Bronchiectasthma and asthmectasis!
    Eur Respir J. 2016;47:1597-600.
    PubMed     Text format    


    May 2016
  201. DEN OTTER I, Willems LN, van Schadewijk A, van Wijngaarden S, et al
    Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells.
    Eur Respir J. 2016 May 26. pii: ERJ-01525-2015. doi: 10.1183/13993003.01525-2015
    PubMed     Text format     Abstract available


  202. SUBRAMANIAN DR, Gupta S, Burggraf D, Vom Silberberg SJ, et al
    Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.
    Eur Respir J. 2016 May 26. pii: ERJ-01878-2015. doi: 10.1183/13993003.01878-2015
    PubMed     Text format     Abstract available


  203. DUCHARME FM, Gagnon R, Benard B, Tse SM, et al
    Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids.
    Eur Respir J. 2016 May 26. pii: ERJ-00014-2016. doi: 10.1183/13993003.00014-2016
    PubMed     Text format    


  204. VASBINDER EC, Goossens LM, Rutten-van Molken MP, de Winter BC, et al
    e-Monitoring of Asthma Therapy to Improve Compliance in children (e-MATIC): a randomised controlled trial.
    Eur Respir J. 2016 May 26. pii: ERJ-01698-2015. doi: 10.1183/13993003.01698-2015
    PubMed     Text format     Abstract available


  205. CHIH AH, Chen YC, Tu YK, Huang KC, et al
    Mediating pathways from central obesity to childhood asthma: a population-based longitudinal study.
    Eur Respir J. 2016 May 12. pii: ERJ-00226-2016. doi: 10.1183/13993003.00226-2016
    PubMed     Text format     Abstract available


  206. SVENNINGSEN S, Nair P, Guo F, McCormack DG, et al
    Is ventilation heterogeneity related to asthma control?
    Eur Respir J. 2016 May 12. pii: ERJ-00393-2016. doi: 10.1183/13993003.00393-2016
    PubMed     Text format     Abstract available


    April 2016
  207. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Text format     Abstract available


  208. LUM S, Stocks J
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1292-3.
    PubMed     Text format    


  209. HULS A, Kramer U, Schuster A, Gappa M, et al
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1290-2.
    PubMed     Text format    


  210. GOMEZ C, Chanez P
    The lung microbiome: the perfect culprit for COPD exacerbations?
    Eur Respir J. 2016;47:1034-6.
    PubMed     Text format    


  211. BOUSQUET J, Barbara C, Bateman E, Bel E, et al
    AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.
    Eur Respir J. 2016;47:1028-33.
    PubMed     Text format    


  212. SPRUIT MA, Franssen FM, Rutten EP, Wopereis S, et al
    A new perspective on COPD exacerbations: monitoring impact by measuring physical, psychological and social resilience.
    Eur Respir J. 2016;47:1024-7.
    PubMed     Text format    


  213. COSTA C, Traves SL, Tudhope SJ, Fenwick PS, et al
    Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD.
    Eur Respir J. 2016;47:1093-102.
    PubMed     Text format     Abstract available


  214. CHARUSUSIN N, Gosselink R, McConnell A, Demeyer H, et al
    Inspiratory muscle training improves breathing pattern during exercise in COPD patients.
    Eur Respir J. 2016;47:1261-4.
    PubMed     Text format    


  215. WANG Z, Bafadhel M, Haldar K, Spivak A, et al
    Lung microbiome dynamics in COPD exacerbations.
    Eur Respir J. 2016;47:1082-92.
    PubMed     Text format     Abstract available


  216. DIZIER MH, Nadif R, Margaritte-Jeannin P, Barton SJ, et al
    Interaction between the DNAH9 gene and early smoke exposure in bronchial hyperresponsiveness.
    Eur Respir J. 2016;47:1072-81.
    PubMed     Text format     Abstract available


  217. MUMBY S, Saito J, Adcock IM, Chung KF, et al
    Decreased breath excretion of redox active iron in COPD: a protective failure?
    Eur Respir J. 2016;47:1267-70.
    PubMed     Text format    


    March 2016
  218. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Text format     Abstract available


  219. KOLAHIAN S, Oz HH, Zhou B, Griessinger CM, et al
    The emerging role of myeloid-derived suppressor cells in lung diseases.
    Eur Respir J. 2016;47:967-77.
    PubMed     Text format     Abstract available


  220. BARTOLI ML, Costa F, Malagrino L, Nieri D, et al
    Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines.
    Eur Respir J. 2016;47:978-80.
    PubMed     Text format    


  221. ZAIGHAM S, Wollmer P, Engstrom G
    Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Eur Respir J. 2016;47:742-50.
    PubMed     Text format     Abstract available


    February 2016
  222. BOLAND AC, Hodgekiss C, Hicks F, Edwards A, et al
    Improving end-of-life communication between primary and secondary care within respiratory medicine.
    Eur Respir J. 2016;47:658-60.
    PubMed     Text format    


  223. MOSS RB
    Treating allergic bronchopulmonary aspergillosis: the way forward.
    Eur Respir J. 2016;47:385-7.
    PubMed     Text format    


  224. SORIANO JB, Suissa S
    Ageing lungs and very elderly COPD: anytime and anywhere.
    Eur Respir J. 2016;47:379-81.
    PubMed     Text format    


  225. LANKEIT M, Held M
    Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?
    Eur Respir J. 2016;47:369-73.
    PubMed     Text format    


  226. AGUSTI A, Bel E, Thomas M, Vogelmeier C, et al
    Treatable traits: toward precision medicine of chronic airway diseases.
    Eur Respir J. 2016;47:410-9.
    PubMed     Text format     Abstract available


  227. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  228. MIRAVITLLES M, Vogelmeier C, Roche N, Halpin D, et al
    A review of national guidelines for management of COPD in Europe.
    Eur Respir J. 2016;47:625-37.
    PubMed     Text format     Abstract available


  229. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


  230. LUOTO JA, Elmstahl S, Wollmer P, Pihlsgard M, et al
    Incidence of airflow limitation in subjects 65-100 years of age.
    Eur Respir J. 2016;47:461-72.
    PubMed     Text format     Abstract available


  231. BORVIK T, Braekkan SK, Enga K, Schirmer H, et al
    COPD and risk of venous thromboembolism and mortality in a general population.
    Eur Respir J. 2016;47:473-81.
    PubMed     Text format     Abstract available


  232. MAGNUSSEN H, Tetzlaff K, Bateman ED, Watz H, et al
    Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.
    Eur Respir J. 2016;47:651-4.
    PubMed     Text format    


  233. GARDEN FL, Simpson JM, Mellis CM, Marks GB, et al
    Change in the manifestations of asthma and asthma-related traits in childhood: a latent transition analysis.
    Eur Respir J. 2016;47:499-509.
    PubMed     Text format     Abstract available


    January 2016
  234. ELLIOTT L, von Essen S
    COPD in farmers: what have we learnt?
    Eur Respir J. 2016;47:16-8.
    PubMed     Text format    


  235. SANSORES RH, Ramirez-Venegas A
    COPD in women: susceptibility or vulnerability?
    Eur Respir J. 2016;47:19-22.
    PubMed     Text format    


  236. WELTE T
    Acute exacerbation in COPD: we must do more.
    Eur Respir J. 2016;47:14-5.
    PubMed     Text format    


  237. LAHOUSSE L, Moyse E, Krantic S, Brusselle GG, et al
    Understanding age-related diseases: report of the 2015 Ageing Summit.
    Eur Respir J. 2016;47:5-9.
    PubMed     Text format    


  238. SHAHEEN SO, Macdonald-Wallis C, Lawlor DA, Henderson AJ, et al
    Hypertensive disorders of pregnancy, respiratory outcomes and atopy in childhood.
    Eur Respir J. 2016;47:156-65.
    PubMed     Text format     Abstract available


  239. HARTL S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, et al
    Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.
    Eur Respir J. 2016;47:113-21.
    PubMed     Text format     Abstract available


  240. GUILLIEN A, Puyraveau M, Soumagne T, Guillot S, et al
    Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study.
    Eur Respir J. 2016;47:95-103.
    PubMed     Text format     Abstract available


  241. CURROW DC, Abernethy AP, Allcroft P, Banzett RB, et al
    The need to research refractory breathlessness.
    Eur Respir J. 2016;47:342-3.
    PubMed     Text format    


  242. LEAHY TR, McManus R, Doherty DG, Grealy R, et al
    Interleukin-15 is associated with disease severity in viral bronchiolitis.
    Eur Respir J. 2016;47:212-22.
    PubMed     Text format     Abstract available


  243. LAZAR Z, Mullner N, Lucattelli M, Ayata CK, et al
    NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Eur Respir J. 2016;47:254-63.
    PubMed     Text format     Abstract available


  244. MOTTE S, Melot C, Di Pierdomenico L, Martins D, et al
    Predictors of costs from the hospital perspective of primary pulmonary embolism.
    Eur Respir J. 2016;47:203-11.
    PubMed     Text format     Abstract available


  245. RADEMACHER J, Schulz A, Hedtfeld S, Stanke F, et al
    Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2016;47:322-4.
    PubMed     Text format    


  246. GABROVSKA M, Lacombe E, Bruyneel M, Ninane V, et al
    Acute bronchospasm during passive exposure to bronchial provocation tests.
    Eur Respir J. 2016;47:320-2.
    PubMed     Text format    


  247. YANG JY, Oh SY, Song JW, Shim TS, et al
    Restrictive chronic lung function decline after haematopoietic stem cell transplantation.
    Eur Respir J. 2016;47:336-9.
    PubMed     Text format    


  248. SUISSA S
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:354-5.
    PubMed     Text format    


  249. LETTIS S, Keene O
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:353-4.
    PubMed     Text format    


    December 2015
  250. POPOVIC M, Rusconi F, Zugna D, Galassi C, et al
    Prenatal exposure to antibiotics and wheezing in infancy: a birth cohort study.
    Eur Respir J. 2015 Dec 2. pii: ERJ-00315-2015. doi: 10.1183/13993003.00315-2015.
    PubMed     Text format     Abstract available


    October 2015
  251. COX DW, Mullane D, Zhang GC, Turner SW, et al
    Longitudinal assessment of airway responsiveness from 1 month to 18 years in the PIAF birth cohort.
    Eur Respir J. 2015 Oct 22. pii: ERJ-00397-2015. doi: 10.1183/13993003.00397-2015
    PubMed     Text format     Abstract available


  252. YAMMINE S, Schmidt A, Sutter O, Fouzas S, et al
    Functional evidence for continued alveolarisation in former preterms at school age?
    Eur Respir J. 2015 Oct 22. pii: ERJ-00478-2015. doi: 10.1183/13993003.00478-2015
    PubMed     Text format     Abstract available


    August 2015
  253. MCKEON NJ, Timmins SN, Stewart H, Yerkovich ST, et al
    Diagnosis of COPD before cardiac surgery.
    Eur Respir J. 2015 Aug 20. pii: ERJ-02339-2014. doi: 10.1183/13993003.02339-2014
    PubMed     Text format    


    July 2015
  254. GAUVREAU GM, El-Gammal AI, O'Byrne PM
    Allergen-induced airway responses.
    Eur Respir J. 2015 Jul 23. pii: ERJ-00536-2015. doi: 10.1183/13993003.00536-2015
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: